| 000 | 00874 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250513130441.0 | ||
| 264 | 0 | _c19971204 | |
| 008 | 199712s 0 0 eng d | ||
| 022 | _a0952-8180 | ||
| 024 | 7 |
_a10.1016/s0952-8180(97)00156-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLubarsky, D A | |
| 245 | 0 | 0 |
_aUnderstanding the term "cost-effectiveness". _h[electronic resource] |
| 260 |
_bJournal of clinical anesthesia _cNov 1997 |
||
| 300 |
_a603-4 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aBlood Transfusion, Autologous _xeconomics |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aHemodilution |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntraoperative Period |
| 773 | 0 |
_tJournal of clinical anesthesia _gvol. 9 _gno. 7 _gp. 603-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0952-8180(97)00156-6 _zAvailable from publisher's website |
| 999 |
_c9318079 _d9318079 |
||